1. Home
  2. GEO vs AKRO Comparison

GEO vs AKRO Comparison

Compare GEO & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEO
  • AKRO
  • Stock Information
  • Founded
  • GEO 1984
  • AKRO 2017
  • Country
  • GEO United States
  • AKRO United States
  • Employees
  • GEO N/A
  • AKRO N/A
  • Industry
  • GEO Homebuilding
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEO Consumer Discretionary
  • AKRO Health Care
  • Exchange
  • GEO Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • GEO 1.9B
  • AKRO 2.1B
  • IPO Year
  • GEO 1994
  • AKRO 2019
  • Fundamental
  • Price
  • GEO $24.42
  • AKRO $35.15
  • Analyst Decision
  • GEO Strong Buy
  • AKRO Strong Buy
  • Analyst Count
  • GEO 2
  • AKRO 7
  • Target Price
  • GEO $17.88
  • AKRO $43.20
  • AVG Volume (30 Days)
  • GEO 3.9M
  • AKRO 538.4K
  • Earning Date
  • GEO 11-07-2024
  • AKRO 11-15-2024
  • Dividend Yield
  • GEO N/A
  • AKRO N/A
  • EPS Growth
  • GEO N/A
  • AKRO N/A
  • EPS
  • GEO 0.18
  • AKRO N/A
  • Revenue
  • GEO $2,424,264,000.00
  • AKRO N/A
  • Revenue This Year
  • GEO $2.31
  • AKRO N/A
  • Revenue Next Year
  • GEO $2.31
  • AKRO N/A
  • P/E Ratio
  • GEO $132.93
  • AKRO N/A
  • Revenue Growth
  • GEO N/A
  • AKRO N/A
  • 52 Week Low
  • GEO $9.09
  • AKRO $13.39
  • 52 Week High
  • GEO $24.58
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • GEO 85.23
  • AKRO 72.72
  • Support Level
  • GEO $13.59
  • AKRO $31.12
  • Resistance Level
  • GEO $16.47
  • AKRO $32.95
  • Average True Range (ATR)
  • GEO 1.05
  • AKRO 1.56
  • MACD
  • GEO 0.71
  • AKRO 0.37
  • Stochastic Oscillator
  • GEO 98.56
  • AKRO 94.19

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: